The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section

• Status: Completed
• Trial end date: 2017-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

The primary endpoint of this study is to investigate the effect of adding nalbuphine to intrathecal morphine on quality of postoperative analgesia and Morphine related side effects post- cesarean delivery.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Abdelrady S Ibrahim, MD
• Treatments: Analgesics; Morphine; Nalbuphine

Criteria

Inclusion Criteria:

• Female patients

• age between 16 to 40 years

• ASA physical status I - II

Exclusion Criteria:

• Infection at the site of injection.

• Coagulopathy or other bleeding diathesis.

• Preexisting neurologic deficits.

• History of hypersensitivity to any of the given the drugs.

• Inability to communicate with the investigator and the hospital staff.

• History of chronic opioid us